Monti Simonetta, Galimberti Viviana, Trifiro Giuseppe, De Cicco Concetta, Peradze Nicolas, Brenelli Fabricio, Fernandez-Rodriguez Julia, Rotmensz Nicole, Latronico Antuono, Berrettini Anastasio, Mauri Manuela, Machado Leonidas, Luini Alberto, Paganelli Giovanni
Division of Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy.
Ann Surg Oncol. 2007 Oct;14(10):2928-31. doi: 10.1245/s10434-007-9452-2. Epub 2007 Aug 1.
Non-palpable breast lesions are diagnosed frequently posing the problem of localization and removal. When such lesions are malignant, axillary node status must be determined. We report our experience using radio-guided occult lesion localization (ROLL) for locating and removing non-palpable breast lesions together with sentinel node biopsy (SNB) to assess axillary status. We call the technique SNOLL.
From March 1997 to April 2004, 1046 consecutive patients presented suspicious non-palpable breast lesions and were programmed for conservative surgery and SNB. In 87 patients intraoperative histological examination revealed a benign lesion and SNB was not performed. The remaining 959 patients, with cytologically or histologically proven cancer, underwent SNOLL with immobile radiotracer injected under mammographic or ultrasound (US) guidance into the lesion, and subsequent injection of mobile tracer subdermally to localize the sentinel node (SN). Patients then underwent breast surgery and SNB.
Breast lesions were localized by ROLL in 99.6% of cases and were removed radically with negative margins in 91.9% of cases. Sentinel nodes were detected in all but one case. Intraoperative or definitive histological examination revealed 776 invasive/microinvasive carcinomas and 182 with in situ disease. Sentinel nodes were positive in 154 (19.8%) of 776 invasive/microinvasive cancers and in two with ductal intraepithelial neoplasia (1.1%).
In SNOLL the injection procedures are performed separately, but both lesion and SNs are removed together; axillary dissection is performed if the SN is positive, thus definitive treatment of malignant non-palpable lesions occurs in a single surgical session.
不可触及的乳腺病变常需诊断,这带来了定位和切除的问题。当此类病变为恶性时,必须确定腋窝淋巴结状态。我们报告了使用放射性引导隐匿性病变定位(ROLL)来定位和切除不可触及乳腺病变并结合前哨淋巴结活检(SNB)以评估腋窝状态的经验。我们将该技术称为SNOLL。
1997年3月至2004年4月,1046例连续患者出现可疑的不可触及乳腺病变,并计划进行保乳手术和SNB。87例患者术中组织学检查显示为良性病变,未进行SNB。其余959例经细胞学或组织学证实为癌症的患者,接受了SNOLL,在乳腺X线摄影或超声(US)引导下将固定放射性示踪剂注入病变,随后在皮下注射移动示踪剂以定位前哨淋巴结(SN)。患者随后接受乳腺手术和SNB。
99.6%的病例通过ROLL定位了乳腺病变,91.9%的病例切缘阴性彻底切除。除1例病例外,所有病例均检测到前哨淋巴结。术中或最终组织学检查显示776例浸润性/微浸润性癌和182例原位疾病。776例浸润性/微浸润性癌中有154例(19.8%)前哨淋巴结阳性,2例导管原位癌(1.1%)前哨淋巴结阳性。
在SNOLL中,注射程序是分开进行的,但病变和SNs一起切除;如果SN阳性则进行腋窝清扫,因此不可触及恶性病变的确定性治疗在一次手术中完成。